JPS5619878B2 - - Google Patents

Info

Publication number
JPS5619878B2
JPS5619878B2 JP4930876A JP4930876A JPS5619878B2 JP S5619878 B2 JPS5619878 B2 JP S5619878B2 JP 4930876 A JP4930876 A JP 4930876A JP 4930876 A JP4930876 A JP 4930876A JP S5619878 B2 JPS5619878 B2 JP S5619878B2
Authority
JP
Japan
Prior art keywords
epi
daunomycin
adriamycin
demethoxy
daunosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4930876A
Other languages
English (en)
Other versions
JPS51133262A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS51133262A publication Critical patent/JPS51133262A/ja
Publication of JPS5619878B2 publication Critical patent/JPS5619878B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • GPHYSICS
    • G04HOROLOGY
    • G04BMECHANICALLY-DRIVEN CLOCKS OR WATCHES; MECHANICAL PARTS OF CLOCKS OR WATCHES IN GENERAL; TIME PIECES USING THE POSITION OF THE SUN, MOON OR STARS
    • G04B37/00Cases
    • G04B37/0008Cases for pocket watches and wrist watches
    • G04B37/0025Cases for pocket watches and wrist watches with cover or bottom with a spring (savonette) bench watches opening or closing with spring action G04B37/0463
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP51049308A 1975-04-30 1976-04-28 Antiitumor glycoside and preparation thereof Granted JPS51133262A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB18098/75A GB1506200A (en) 1975-04-30 1975-04-30 Glycosides

Publications (2)

Publication Number Publication Date
JPS51133262A JPS51133262A (en) 1976-11-18
JPS5619878B2 true JPS5619878B2 (ja) 1981-05-09

Family

ID=10106621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51049308A Granted JPS51133262A (en) 1975-04-30 1976-04-28 Antiitumor glycoside and preparation thereof

Country Status (16)

Country Link
US (1) US4112076A (ja)
JP (1) JPS51133262A (ja)
AT (1) AT345457B (ja)
AU (1) AU500439B2 (ja)
BE (1) BE841266A (ja)
CA (1) CA1061335A (ja)
CH (1) CH624125A (ja)
DE (1) DE2618822C3 (ja)
DK (1) DK150203C (ja)
ES (1) ES447433A1 (ja)
FR (1) FR2309234A1 (ja)
GB (1) GB1506200A (ja)
NL (1) NL179587C (ja)
SE (2) SE431875B (ja)
SU (1) SU728719A3 (ja)
ZA (1) ZA762562B (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374333A1 (fr) * 1976-12-20 1978-07-13 Inst Int Pathologie Cellulaire Nouveaux derives du naphtacene, leur preparation et les compositions qui les contiennent
GB1550879A (en) * 1976-12-22 1979-08-22 Farmaceutici Italia Antitumour glycosides
GB1567392A (en) * 1977-02-22 1980-05-14 Farmaceutici Italia Daunorubicin derivatives
US4201773A (en) * 1978-07-26 1980-05-06 The United States Of America As Represented By The Department Of Health, Education And Welfare 7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
IT1196402B (it) * 1978-11-21 1988-11-16 Erba Farmitalia Antibiotici antitumorali
NL8001417A (nl) * 1979-03-17 1980-09-19 Erba Farmitalia Antitumorglycosiden.
BE884828A (fr) * 1979-08-20 1981-02-19 Hoffmann La Roche Derives de naphtacene
EP0024727B1 (en) * 1979-09-01 1982-05-26 FARMITALIA CARLO ERBA S.p.A. Anthracycline glycosides, processes for their preparation and pharmaceutical composition containing them
US4345068A (en) * 1979-11-22 1982-08-17 Farmitalia Carlo Erba S.P.A. Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process
US4301276A (en) * 1980-03-07 1981-11-17 Purdue University Synthesis of daunosamine hydrochloride and intermediates used in its preparation
US4298726A (en) * 1980-03-07 1981-11-03 Purdue University Synthesis of N-benzoyl-L-ristosamine and intermediates used in its preparation
US4345070A (en) * 1980-09-29 1982-08-17 Farmitalia Carlo Erba S.P.A. Process for the preparation of 4'-deoxy-daunorubicin and 4'-deoxy-doxorubicin
US5138042A (en) * 1981-05-28 1992-08-11 Farmitalia Carlo Erba S.P.A. 6-deoxyanthracyclines
AU549656B2 (en) * 1981-09-18 1986-02-06 Farmitalia Carlo Erba S.P.A. Anthracycline glycoside antitumor agents
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB2196626B (en) * 1986-10-15 1990-09-19 Erba Farmitalia Antitumor anthracycline glycosides, their preparation, intermediates thereof, and compositions and use therefor
DE3641835A1 (de) * 1986-12-08 1988-06-16 Behringwerke Ag Zytostatisch wirksame anthracyclinderivate
GB8803076D0 (en) * 1988-02-10 1988-03-09 Erba Carlo Spa 3'-deamino-4'-deoxy-4'-amino anthracyclines
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
ATE520702T1 (de) * 2003-07-02 2011-09-15 Solux Corp Thermisch stabiles kristallines epirubicin- hydrochlorid und herstellungsverfahren dafür
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
WO2007070820A2 (en) * 2005-12-13 2007-06-21 Solux Corporation Method for preparing 4-demethyldaunorubicin
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
PL2301943T3 (pl) * 2009-09-08 2014-06-30 Heraeus Precious Metals Gmbh Krystalizacja epidaunorubicyny x HCI
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
CN103204888B (zh) * 2012-01-15 2016-08-17 山东新时代药业有限公司 一种盐酸表柔比星中间体的制备方法
TWI712611B (zh) 2015-03-30 2020-12-11 日商明治製菓藥業股份有限公司 泛艾黴素之製造方法及其新穎之製造中間體

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803124A (en) * 1968-04-12 1974-04-09 Farmaceutici It Soc Process for the preparation of adriamycin and adriamycinone and adriamycin derivatives
GB1467383A (en) * 1974-06-12 1977-03-16 Farmaceutici Italia Daunomycin analogues
GB1470860A (en) * 1974-10-29 1977-04-21 Farmaceutici Italia Anthracycline glycosides

Also Published As

Publication number Publication date
CA1061335A (en) 1979-08-28
SE7604908L (sv) 1976-10-31
AU1339076A (en) 1977-11-03
DE2618822B2 (de) 1982-09-16
FR2309234A1 (fr) 1976-11-26
NL179587B (nl) 1986-05-01
SE431875B (sv) 1984-03-05
DK150203B (da) 1987-01-05
CH541176A4 (ja) 1981-07-15
JPS51133262A (en) 1976-11-18
DK150203C (da) 1987-11-02
FR2309234B1 (ja) 1978-08-25
ATA302676A (de) 1978-01-15
CH624125A (ja) 1981-07-15
US4112076A (en) 1978-09-05
SE436884B (sv) 1985-01-28
AT345457B (de) 1978-09-25
NL179587C (nl) 1986-10-01
DE2618822A1 (de) 1976-11-11
SE8001615L (sv) 1980-02-29
BE841266A (fr) 1976-10-29
AU500439B2 (en) 1979-05-24
SU728719A3 (ru) 1980-04-15
DK189676A (da) 1976-10-31
DE2618822C3 (de) 1983-04-28
GB1506200A (en) 1978-04-05
ES447433A1 (es) 1977-07-01
NL7604049A (nl) 1976-11-02
ZA762562B (en) 1977-04-27

Similar Documents

Publication Publication Date Title
FR2309234B1 (ja)
MY103912A (en) Adriamycin
SE7508450L (sv) Antitumorantibiotika aklacinomycin a och b.
AU1802576A (en) Anthracycline glycosides
PT66067B (en) Process for preparing novel anthracycline glycosides
ES463684A1 (es) Un procedimiento para preparar nuevos derivados de aminogli-cosido.
ES442144A1 (es) Un procedimiento para la preparacion de 4'-epi-6'-hidroxida-unomicina.
CA991574A (en) Process for preparing soluble flavonoid glycosides
DE3060472D1 (en) Anthracycline glycosides, processes for their preparation and pharmaceutical composition containing them
ES472306A1 (es) Un procedimiento para la produccion de un glicosido de an- traciclina
JPS5379851A (en) Novel anthracycline system glycoside process for preparing same and antitumor medicine containing same
ES8302733A1 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
MY103552A (en) Saccharide derivatives
JPS5363367A (en) Novel disaccaride derivative of anthracycline process for preparing same and antitumor medicine containing same
ES8504252A1 (es) Un procedimiento para producir derivados de antraciclina
GR3001717T3 (en) A doxorubicin derivative, a process for preparing the same, pharmaceutical preparations comprising the same, and the use of the same for the manufacture of useful medicaments
JPS55130996A (en) Novel maltose derivative and its preparation
IE831141L (en) Anthracycline glycosides
DE3476398D1 (en) An anthracycline compound, a process for the production thereof, a pharmaceutical composition containing the same and its use as a medicament
IE800511L (en) Antitumour glycosides
JPS5282790A (en) Preparation of macroride antibiotics
GB1389033A (en) Cardenolide- and buadienolide-glycosides and process for their preparation
JPS6426590A (en) Anthracycline antibiotic having antitumor action
OA04712A (fr) Procédé de préparation de dérivés acylés de l'antibiotique.